Pacifica Partners’s CRISPR Therapeutics CRSP Stock Holding History

Pacifica Partners’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.8K	Hold	30	–	–	﹤0.01%	398
2026 Q1	$1.43K	Hold	30	–	–	﹤0.01%	424
2025 Q4	$1.61K	Hold	30	–	–	﹤0.01%	407
2025 Q3	$1.98K	Hold	30	–	–	﹤0.01%	462
2025 Q2	$1.43K	Hold	30	–	–	﹤0.01%	489
2025 Q1	$979	Hold	30	–	–	﹤0.01%	483
2024 Q4	$1.24K	Hold	30	–	–	﹤0.01%	448
2024 Q3	$1.41K	Hold	30	–	–	﹤0.01%	467
2024 Q2	$1.62K	Hold	30	–	–	﹤0.01%	483
2024 Q1	$2.13K	Hold	30	–	–	﹤0.01%	459
2023 Q4	$2.12K	Hold	30	–	–	﹤0.01%	485
2023 Q3	$1.29K	Hold	30	–	–	﹤0.01%	491
2023 Q2	$1.7K	Hold	30	–	–	﹤0.01%	435
2023 Q1	$1.36K	Hold	30	–	–	﹤0.01%	454
2022 Q4	$1.23K	Hold	30	–	–	﹤0.01%	437
2022 Q3	$2K	Hold	30	–	–	﹤0.01%	422
2022 Q2	$2K	Hold	30	–	–	﹤0.01%	437
2022 Q1	$2K	Hold	30	–	–	﹤0.01%	433
2021 Q4	$2K	Hold	30	–	–	﹤0.01%	430
2021 Q3	$3K	Hold	30	–	–	﹤0.01%	400
2021 Q2	$5K	Buy	+30	New	+$3.65K	﹤0.01%	351
2020 Q2	–	Sell	-50	Closed	-$2K	–	379
2020 Q1	$2K	Hold	50	–	–	﹤0.01%	322
2019 Q4	$3K	Buy	+50	New	+$2.73K	﹤0.01%	307

Other funds holding CRSP

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Slow Capital Greenbrae, California $857M AUM 38.3% 1-Year Est. Return

BEI

Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return

CIC

Canal Insurance Company Greenville, South Carolina $456M AUM 40.11% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

WETS

Wealth Enhancement Trust Services Sioux Falls, South Dakota $900M AUM

BIP

Bouvel Investment Partners Phoenixville, Pennsylvania $442M AUM 70.77% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Pacifica Partners's CRSP Position: Q2 2026 in Review

Pacifica Partners held its CRISPR Therapeutics (CRSP) position steady in Q2 2026 at 30 shares worth $1.8K. The position accounts for ﹤0.01% of the portfolio, ranked #398.

Pacifica Partners first reported a position in CRSP in Q4 2019 and has held it in 23 quarters since. The position peaked at $5K in Q2 2021. 109 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

Pacifica Partners held 30 shares of CRISPR Therapeutics worth $1.8K as of Q2 2026.
Pacifica Partners left its CRISPR Therapeutics share count unchanged in Q2 2026.
CRISPR Therapeutics made up ﹤0.01% of Pacifica Partners's portfolio in Q2 2026, its #398 holding.
Pacifica Partners first reported a position in CRISPR Therapeutics in Q4 2019 and has held it in 23 quarters since.
Pacifica Partners's CRISPR Therapeutics position peaked at $5K in Q2 2021.
109 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on Pacifica Partners's 13F filing for Q2 2026, filed 13 Jul 2026.